Living With Small Cell Lung Cancer (SCLC): Current Therapies and Looking Towards the Future

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 40 Minutes

Overview

This program delivers a comprehensive review of small cell lung cancer, focusing on contemporary approaches to diagnosis, staging, and management across limited- and extensive-stage disease. Participants will examine current standards of care, including chemoimmunotherapy, radiation strategies, and supportive care considerations, while gaining insight into emerging therapies and clinical trials that are shaping the future treatment landscape for patients living with SCLC.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Discuss pathology, diagnosis and staging of SCLC
  2. Describe treatment options and related supportive care management for limited SCLC
  3. Identify first-line treatment strategies for extensive-stage small cell lung cancer (ES-SCLC), approaches to supportive care, and considerations for selecting second-line and subsequent therapies
  4. Discuss new therapies and current promising investigational agents and related toxicities

                                                                                          

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
01/20/2026
Course expires: 
01/23/2027
Cost:
$0.00
Rating: 
0

Faculty

Rebecca Wilman Repetti, ANP-BC, AOCNP

Clinical Trials Nurse Practitioner
Memorial Sloan Kettering Cancer Center
New York, NY

Rebecca Wildman Repetti is a clinical trials nurse practitioner for the thoracic oncology service at Memorial Sloan-Kettering Cancer Center. She received her BSN from Columbia University School of Nursing in 2005 and her MSN in Adult Health with a subspeciality in oncology from Columbia University in 2008.

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Rebecca Wilman Repetti, ANP-BC, AOCNP discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients during the past 24 months.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above